Safety and Efficacy of Cannabis in Autism Spectrum Disorder

Investigators from the Soroka University Medical Centre, The Hebrew University of Jerusalem, and Tikun Olam Ltd. in Israel studied the safety and efficacy of medical cannabis treatment on 188 patients with autism spectrum disorder (ASD) for six months.

Detalles Bibliográficos
Autores principales: Ganesh, Abhinaya, Shareef, Safiullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pediatric Neurology Briefs Publishers 2020
Materias:
Neurodevelopmental Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759327/
https://www.ncbi.nlm.nih.gov/pubmed/33376294
http://dx.doi.org/10.15844/pedneurbriefs-34-25
_version_ 1783627095213080576
author Ganesh, Abhinaya
Shareef, Safiullah
author_facet Ganesh, Abhinaya
Shareef, Safiullah
author_sort Ganesh, Abhinaya
collection PubMed
description Investigators from the Soroka University Medical Centre, The Hebrew University of Jerusalem, and Tikun Olam Ltd. in Israel studied the safety and efficacy of medical cannabis treatment on 188 patients with autism spectrum disorder (ASD) for six months.
format Online
Article
Text
id pubmed-7759327
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Pediatric Neurology Briefs Publishers
record_format MEDLINE/PubMed
spelling pubmed-77593272020-12-28 Safety and Efficacy of Cannabis in Autism Spectrum Disorder Ganesh, Abhinaya Shareef, Safiullah Pediatr Neurol Briefs Neurodevelopmental Disorders Investigators from the Soroka University Medical Centre, The Hebrew University of Jerusalem, and Tikun Olam Ltd. in Israel studied the safety and efficacy of medical cannabis treatment on 188 patients with autism spectrum disorder (ASD) for six months. Pediatric Neurology Briefs Publishers 2020-12-24 /pmc/articles/PMC7759327/ /pubmed/33376294 http://dx.doi.org/10.15844/pedneurbriefs-34-25 Text en Copyright: © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Neurodevelopmental Disorders
Ganesh, Abhinaya
Shareef, Safiullah
Safety and Efficacy of Cannabis in Autism Spectrum Disorder
title Safety and Efficacy of Cannabis in Autism Spectrum Disorder
title_full Safety and Efficacy of Cannabis in Autism Spectrum Disorder
title_fullStr Safety and Efficacy of Cannabis in Autism Spectrum Disorder
title_full_unstemmed Safety and Efficacy of Cannabis in Autism Spectrum Disorder
title_short Safety and Efficacy of Cannabis in Autism Spectrum Disorder
title_sort safety and efficacy of cannabis in autism spectrum disorder
topic Neurodevelopmental Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759327/
https://www.ncbi.nlm.nih.gov/pubmed/33376294
http://dx.doi.org/10.15844/pedneurbriefs-34-25
work_keys_str_mv AT ganeshabhinaya safetyandefficacyofcannabisinautismspectrumdisorder
AT shareefsafiullah safetyandefficacyofcannabisinautismspectrumdisorder

Ejemplares similares